DE602005019398D1 - LIQUIDS WITH SUSPENDED GLASS PARTICLES - Google Patents
LIQUIDS WITH SUSPENDED GLASS PARTICLESInfo
- Publication number
- DE602005019398D1 DE602005019398D1 DE602005019398T DE602005019398T DE602005019398D1 DE 602005019398 D1 DE602005019398 D1 DE 602005019398D1 DE 602005019398 T DE602005019398 T DE 602005019398T DE 602005019398 T DE602005019398 T DE 602005019398T DE 602005019398 D1 DE602005019398 D1 DE 602005019398D1
- Authority
- DE
- Germany
- Prior art keywords
- liquids
- particles
- glass particles
- suspended
- suspended glass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Glass Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
A pharmaceutical composition comprising a biologically active agent preserved in particulate form, in particular a glass or amorphous particle, such as a sugar, a metal carboxylate, an amino acid or calcium phosphate, wherein said particles are suspended in at least one of a hydrofluoroether, a perfluoroether, a hydrofluoroamine, a perfluoroamine, a hydrofluorothioether, a perfluorothioether, a hydrofluoropolyether or a perfluoropolyether. The use of such fluorinated liquid media overcomes the problem of aggregation of particles and also is environmentally friendly.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0408199.8A GB0408199D0 (en) | 2004-04-13 | 2004-04-13 | Liquids containing suspended sugar glass particles |
GB0504501A GB2413075B (en) | 2004-04-13 | 2005-03-07 | Liquids containing suspended glass particles |
PCT/GB2005/050050 WO2005099669A1 (en) | 2004-04-13 | 2005-04-13 | Liquids containing suspended glass particles |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005019398D1 true DE602005019398D1 (en) | 2010-04-01 |
Family
ID=32320732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005019398T Active DE602005019398D1 (en) | 2004-04-13 | 2005-04-13 | LIQUIDS WITH SUSPENDED GLASS PARTICLES |
Country Status (10)
Country | Link |
---|---|
CN (1) | CN1942171B (en) |
AT (1) | ATE457717T1 (en) |
DE (1) | DE602005019398D1 (en) |
DK (1) | DK1750668T3 (en) |
ES (1) | ES2339783T3 (en) |
GB (2) | GB0408199D0 (en) |
MX (1) | MXPA06011895A (en) |
PT (1) | PT1750668E (en) |
RU (1) | RU2363447C2 (en) |
ZA (1) | ZA200609158B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0517688D0 (en) * | 2005-08-31 | 2005-10-05 | Cambridge Biostability Ltd | Improvements in the stabilisation of biological materials |
GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
US9243626B2 (en) | 2012-11-19 | 2016-01-26 | Nordson Corporation | Adhesive dispensing system and method including a pump with integrated diagnostics |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07258027A (en) * | 1994-03-16 | 1995-10-09 | Shiseido Co Ltd | Makeup cosmetic |
US6433040B1 (en) * | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
AU2046101A (en) * | 1999-11-22 | 2001-06-04 | Universal Preservation Technologies, Inc. | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
AU2001211986B2 (en) * | 2000-10-13 | 2007-04-26 | Cambridge Biostability Ltd. | Composition and method for stable injectable liquids |
-
2004
- 2004-04-13 GB GBGB0408199.8A patent/GB0408199D0/en not_active Ceased
-
2005
- 2005-03-07 GB GB0504501A patent/GB2413075B/en active Active
- 2005-04-13 ES ES05731023T patent/ES2339783T3/en active Active
- 2005-04-13 AT AT05731023T patent/ATE457717T1/en not_active IP Right Cessation
- 2005-04-13 RU RU2006137275/15A patent/RU2363447C2/en not_active IP Right Cessation
- 2005-04-13 CN CN2005800110373A patent/CN1942171B/en not_active Expired - Fee Related
- 2005-04-13 DK DK05731023.7T patent/DK1750668T3/en active
- 2005-04-13 PT PT05731023T patent/PT1750668E/en unknown
- 2005-04-13 DE DE602005019398T patent/DE602005019398D1/en active Active
- 2005-04-13 MX MXPA06011895A patent/MXPA06011895A/en unknown
-
2006
- 2006-11-03 ZA ZA200609158A patent/ZA200609158B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK1750668T3 (en) | 2010-05-10 |
PT1750668E (en) | 2010-04-07 |
GB2413075A (en) | 2005-10-19 |
CN1942171A (en) | 2007-04-04 |
GB0408199D0 (en) | 2004-05-19 |
ZA200609158B (en) | 2008-06-25 |
MXPA06011895A (en) | 2007-11-20 |
GB2413075B (en) | 2009-01-21 |
RU2006137275A (en) | 2008-05-20 |
RU2363447C2 (en) | 2009-08-10 |
CN1942171B (en) | 2011-04-06 |
GB0504501D0 (en) | 2005-04-13 |
ATE457717T1 (en) | 2010-03-15 |
ES2339783T3 (en) | 2010-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Synthesis and characterization of injectable poly (N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links | |
Wu et al. | Slippery liquid-attached surface for robust biofouling resistance | |
DE502005009045D1 (en) | MAGNETORHEOLOGICAL MATERIALS WITH HIGH SWITCHING FACTOR AND ITS USE | |
HK1135609A1 (en) | Formation of medically useful gels comprising microporous particles and methods of use | |
GB2464038A (en) | System, method, and apparatus for combined fracturing treatment and scale inhibition | |
EP2335575A3 (en) | Magnetic gas bubble composition and magnetic gas bubble precursor for its manufacture | |
WO2007111681A3 (en) | Device and methods for liquid crystal-based bioagent detection | |
EA200701884A1 (en) | FOOD LIPID COMPOSITION IN THE FORM OF PARTICLES | |
ATE546130T1 (en) | DISPERSION OF POLYMER PARTICLES | |
FR2856692A1 (en) | PROCESS FOR THE PREPARATION OF POLYAMIDE-BASED SPHERICAL PARTICLES. | |
EA200802140A1 (en) | LIQUID COMPOSITION CONTAINING THE ASPARAGIN PROTEAS | |
ATE457717T1 (en) | LIQUIDS WITH SUSPENDED GLASS PARTICLES | |
ATE413419T1 (en) | NEW HYDRGELS BASED ON POLYVINYL ALCOHOLS AND POLYVINYL ALCOHOL COPOLYMERS | |
PL2397510T3 (en) | High concentration pelletized additive concentrates for polymer | |
UA96145C2 (en) | Fat-containing composition and method for improving solubility of fat-containing powders in cold liquids | |
DE60234945D1 (en) | POWDER FOR NASAL ADMINISTRATION OF ACTIVE SUBSTANCES | |
DE602007005146D1 (en) | AMMENSETZUNG | |
TR200102988T2 (en) | Absorbents for use in handling complex liquids. | |
Solomon | Against Valence (“Positive” and “Negative” Emotions)(2001) | |
MX2007005124A (en) | Spontaneously dispersible pharmaceutical compositions. | |
De Leon-Oliva et al. | Advanced Hydrogel-Based Strategies for Enhanced Bone and Cartilage Regeneration: A Comprehensive Review | |
Peng et al. | The surface characteristics of chitosan modified PSt-GMA microspheres influenced the interactions and properties of immobilized pepsin | |
WO2006117113A3 (en) | Halomethylene alkanones and furanones for use as biofilm blocking substances | |
CN202728282U (en) | Improved instrument truck | |
Gauthier et al. | Correction to: Testing the moss layer transfer technique on mineral well pads constructed in peatlands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |